New York’s financial services watchdog is accepting public comments through Feb. 16 on proposed pharmacy benefit manager regulations that are intended to strengthen consumer protections and address anti-competitive conduct.

The proposed set of rules follows New York’s enactment of a 2021 law that is aimed at rooting out the former common practice of spread-pricing, which enables PBMs to charge pharmacists higher prices than they pay to manufacturers, yielding additional unknown profits.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]